Mirum Pharmaceuticals, Inc. — Form 8-K
Filed October 26, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Mirum Pharmaceuticals filed a Form 8-K on 2026-10-26 reporting under Item 8.01 (Other Events). The filing document does not contain specific substantive disclosures—no counterparties, dollar amounts, share counts, dates of transactions, or material business changes are detailed in the provided text. Only metadata and XBRL data structure files are shown.
Why this rating
No material facts disclosed; Item 8.01 is catch-all for non-specified events. Routine SEC filing with no quantified business impact evident.
Extracted items
See more from October 26, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.